# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104506-24-000008
Filing Date
2024-02-22
Accepted
2024-02-22 07:00:23
Documents
115
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | insm-20231231.htm iXBRL | 10-K | 2339075
2 | EX-21.1 | insm20231231ex211.htm | EX-21.1 | 9148
3 | EX-23.1 | insm20231231ex231.htm | EX-23.1 | 3004
4 | EX-31.1 | insm20231231ex311.htm | EX-31.1 | 8066
5 | EX-31.2 | insm20231231ex312.htm | EX-31.2 | 7980
6 | EX-32.1 | insm20231231ex321.htm | EX-32.1 | 5461
7 | EX-32.2 | insm20231231ex322.htm | EX-32.2 | 5616
8 | EX-97 | insm20231231ex97.htm | EX-97 | 23585
14 |  | image_0.jpg | GRAPHIC | 8043
15 |  | insm-20231231_g1.jpg | GRAPHIC | 86778
16 |  | insm-20231231_g2.jpg | GRAPHIC | 35650
| Complete submission text file | 0001104506-24-000008.txt |  | 12854084

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | insm-20231231.xsd | EX-101.SCH | 77775
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | insm-20231231_cal.xml | EX-101.CAL | 132200
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | insm-20231231_def.xml | EX-101.DEF | 480958
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | insm-20231231_lab.xml | EX-101.LAB | 1108297
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | insm-20231231_pre.xml | EX-101.PRE | 780137
117 | EXTRACTED XBRL INSTANCE DOCUMENT | insm-20231231_htm.xml | XML | 1783798

Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30739 | Film No.: 24662241
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)